News

Learn how GLP-1 receptor agonists show promise in reducing alcohol consumption and aiding weight loss in obesity treatment.
There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...
Dopamine deficiency occurs when levels of the neurotransmitter dopamine are low, affecting movement, emotions, sleep, and ...
GLP-1 weight-loss drugs like Ozempic and Wegovy may help reduce alcohol cravings and heavy drinking, offering promising potential in treating alcohol use disorder alongside managing obesity and ...
APPLY TO BE ON THE PODCAST: <a href="https://www.digitalsocialhour.com/application">https://www.digitalsocialhour.com/application</a> BUSINESS INQUIRIES/SPONSORS ...
Weightwatchers and bariatric surgery had limited effects on the obese brain, but GLP-1s like Ozempic may mean new hope in ...
Like opioids, SBI-810 works on the nervous system to relieve pain. The experimental compound is designed to target a receptor ...
The team showed that indeed they express "D1" receptors for the neuromodulator ... The dopamine activity tracking revealed that during the shocks on day 1, Rspo2 neurons had the larger response to ...
The novel PDE10A inhibitor CPL'36 offers a new mechanism of action and is both safe and effective for acute exacerbations of schizophrenia, new research suggests.
Doctors have warned of some hidden and potentially lethal side effects of using Ozempic amid the increasing popularity of the ...
The first time around, 59-year-old James Brown lost a stone and a half when he took medication that aids weight loss. This ...